TSS
GILD icon

Two Sigma Securities’s Gilead Sciences GILD Stock Holding History

Two Sigma Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-45,900
Closed -$3.85M – 2260
2024
Q3 		$3.85M Sell
45,900
-5,500
-11% -$420K 0.07% 348
2024
Q2 		$3.53M Sell
51,400
-200
-0.4% -$13.3K 0.04% 474
2024
Q1 		$3.78M Sell
51,600
-33,800
-40% -$2.6M 0.04% 486
2023
Q4 		$6.92M Sell
85,400
-9,800
-10% -$763K 0.07% 287
2023
Q3 		$7.13M Buy
95,200
+34,900
+58% +$2.68M 0.08% 266
2023
Q2 		$4.65M Buy
60,300
+39,400
+189% +$3.14M 0.07% 319
2023
Q1 		$1.73M Sell
20,900
-17,300
-45% -$1.43M 0.03% 578
2022
Q4 		$3.28M Sell
38,200
-49,200
-56% -$3.9M 0.1% 262
2022
Q3 		$5.39M Sell
87,400
-108,500
-55% -$6.84M 0.16% 132
2022
Q2 		$12.1M Buy
195,900
+128,400
+190% +$7.95M 0.43% 39
2022
Q1 		$4.01M Buy
67,500
+62,000
+1,127% +$3.96M 0.14% 167
2021
Q4 		$399K Sell
5,500
-2,400
-30% -$165K 0.02% 651
2021
Q3 		$552K Sell
7,900
-42,600
-84% -$2.99M 0.02% 730
2021
Q2 		$3.48M Buy
50,500
+44,600
+756% +$2.98M 0.1% 136
2021
Q1 		$381K Sell
5,900
-13,300
-69% -$858K 0.02% 357
2020
Q4 		$1.12M Buy
19,200
+7,300
+61% +$440K 0.03% 364
2020
Q3 		$752K Sell
11,900
-4,900
-29% -$340K 0.02% 441
2020
Q2 		$1.29M Sell
16,800
-39,200
-70% -$3M 0.03% 323
2020
Q1 		$4.19M Sell
56,000
-138,700
-71% -$9.58M 0.09% 136
2019
Q4 		$12.7M Buy
194,700
+89,800
+86% +$5.85M 0.09% 170
2019
Q3 		$6.65M Sell
104,900
-21,700
-17% -$1.42M 0.06% 249
2019
Q2 		$8.55M Buy
126,600
+58,300
+85% +$3.84M 0.09% 138
2019
Q1 		$4.44M Sell
68,300
-3,900
-5% -$259K 0.04% 188
2018
Q4 		$4.52M Sell
72,200
-182,100
-72% -$12.7M 0.06% 173
2018
Q3 		$19.6M Sell
254,300
-53,900
-17% -$4.07M 0.13% 102
2018
Q2 		$21.8M Sell
308,200
-89,900
-23% -$6.35M 0.11% 142
2018
Q1 		$30M Buy
398,100
+322,400
+426% +$25.6M 0.17% 96
2017
Q4 		$5.42M Buy
+75,700
New +$5.75M 0.15% 113

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Two Sigma Securities's GILD Position: Q4 2025 in Review

Two Sigma Securities sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 3,085 shares — an estimated $342K sold.

Two Sigma Securities first reported a position in GILD in Q2 2015 and held it in 25 quarters. The position peaked at $3.92M in Q1 2018. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Two Sigma Securities reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 3,085 Gilead Sciences shares in Q4 2025, an estimated $342K.
  • Two Sigma Securities first reported a position in Gilead Sciences in Q2 2015 and held it in 25 quarters.
  • Two Sigma Securities's Gilead Sciences position peaked at $3.92M in Q1 2018.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.